Under identical conditions, treatment of OSC19 cells with erlotinib also resulted in reversal of epithelial-to-mesenchymal transition in a dose-dependent manner. Presented blots are representative of three independent experiments with similar results. Credit: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0031093
- Under identical conditions, treatment of OSC19 cells with erlotinib also resulted in reversal of epithelial-to-mesenchymal transition in a dose-dependent manner. Presented blots are representative of three independent experiments with similar results.
- Summary of the action of GSPs on the prevention of HNSCC cell invasion
- More >







